...
首页> 外文期刊>The American Journal of Cardiology >Relation of the Bilateral Earlobe Crease to Endothelial Dysfunction
【24h】

Relation of the Bilateral Earlobe Crease to Endothelial Dysfunction

机译:双侧耳垂折痕对内皮功能障碍的关系

获取原文
获取原文并翻译 | 示例

摘要

The presence of an earlobe crease (ELC) may be a simple sign to predict atherosclerosis. We evaluated the relation between ELC and vascular function. We measured flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID) and observed bilateral earlobes in 400 consecutive subjects. At first, the subjects were divided into 3 groups: non-ELC group, unilateral ELC group, and bilateral ELC group. FMD and NID were significantly lower in the unilateral and bilateral ELC groups than those in the non-ELC group. After adjustment of cardiovascular risk factors, bilateral ELC, but not unilateral ELC, was associated with lower FMD and lower NID. We also investigated whether an increase in the number of ELCs worsens endothelial function, whether the difference in ELC structure (cross stripes and/or ramification) affects endothelial function, and whether endothelial function is impaired in subjects with superficial wrinkles depending on age. The number of ELCs, shape of the ELC, and superficial wrinkles were not associated with endothelial dysfunction. In conclusion, these findings suggest that the presence of bilateral ELCs is associated with vascular dysfunction. (C) 2017 Elsevier Inc. All rights reserved.
机译:耳垂折痕(ELC)的存在可能是预测动脉粥样硬化的简单标志。我们评估了ELC与血管功能之间的关系。我们测量流动介导的血管舒张(FMD)和硝酸甘油诱导的血管舒张(NID),并在400个连续受试者中观察到双侧潜脂。首先,将受试者分为3组:非ELC组,单侧ELC组和双侧ELC组。单边和双边ELC组的FMD和NID显着降低,而不是非ELC集团的小组。在调整心血管危险因素后,双侧ELC,但不是单侧ELC,与较低的FMD和低于NID相关。我们还研究了ELCS数量的增加是否恶化内皮功能,无论是ELC结构(交叉条纹和/或分枝)的差异是否会影响内皮功能,以及根据年龄的浅表皱纹的受试者是否受到内皮功能。 ELC的数量,ELC的形状和表面皱纹与内皮功能障碍无关。总之,这些研究结果表明双侧ELC的存在与血管功能障碍有关。 (c)2017年Elsevier Inc.保留所有权利。

著录项

  • 来源
    《The American Journal of Cardiology 》 |2017年第12期| 共6页
  • 作者单位

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Cardiovasc Med Hiroshima;

    Hiroshima Univ Grad Sch Biomed &

    Hlth Sci Inst Biomed &

    Hlth Sci Dept Gastroenterol &

    Metab;

    Hiroshima Int Univ Hiroshima Japan;

    Hiroshima Univ Res Inst Radiat Biol &

    Med Dept Cardiovasc Regenerat &

    Med Hiroshima Japan;

    Hiroshima Univ Res Inst Radiat Biol &

    Med Dept Cardiovasc Regenerat &

    Med Hiroshima Japan;

    Hiroshima Univ Res Inst Radiat Biol &

    Med Dept Cardiovasc Regenerat &

    Med Hiroshima Japan;

    Shizuoka Univ Acad Inst Coll Engn Shizuoka Japan;

    Hiroshima Univ Res Inst Radiat Biol &

    Med Dept Cardiovasc Regenerat &

    Med Hiroshima Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏、血管(循环系)疾病 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号